JP2001525322A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001525322A5 JP2001525322A5 JP2000523214A JP2000523214A JP2001525322A5 JP 2001525322 A5 JP2001525322 A5 JP 2001525322A5 JP 2000523214 A JP2000523214 A JP 2000523214A JP 2000523214 A JP2000523214 A JP 2000523214A JP 2001525322 A5 JP2001525322 A5 JP 2001525322A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- alkyl
- embedded image
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 description 15
- 150000003839 salts Chemical class 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 125000001475 halogen functional group Chemical group 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000005031 thiocyano group Chemical group S(C#N)* 0.000 description 2
- 0 *Cc1c(*)cc(*)cc1* Chemical compound *Cc1c(*)cc(*)cc1* 0.000 description 1
- PXZLZJICBRRFDD-UHFFFAOYSA-N 8-[(2,6-dimethylphenyl)methoxy]-2,3-dimethylimidazo[1,2-a]pyrazine Chemical compound N=1C=CN2C(C)=C(C)N=C2C=1OCC1=C(C)C=CC=C1C PXZLZJICBRRFDD-UHFFFAOYSA-N 0.000 description 1
- 125000005905 mesyloxy group Chemical group 0.000 description 1
- LZFXMIHHUPVZFQ-UHFFFAOYSA-N n-[(2,6-dimethylphenyl)methyl]-2,3-dimethylimidazo[1,2-a]pyrazin-8-amine Chemical compound N=1C=CN2C(C)=C(C)N=C2C=1NCC1=C(C)C=CC=C1C LZFXMIHHUPVZFQ-UHFFFAOYSA-N 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000005424 tosyloxy group Chemical group S(=O)(=O)(C1=CC=C(C)C=C1)O* 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704404-4 | 1997-11-28 | ||
| SE9704404A SE9704404D0 (sv) | 1997-11-28 | 1997-11-28 | New compounds |
| PCT/SE1998/002091 WO1999028322A1 (en) | 1997-11-28 | 1998-11-18 | Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001525322A JP2001525322A (ja) | 2001-12-11 |
| JP2001525322A5 true JP2001525322A5 (enExample) | 2006-01-12 |
Family
ID=20409181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000523214A Pending JP2001525322A (ja) | 1997-11-28 | 1998-11-18 | 胃酸分泌を抑制する複素環式化合物、それらの製造法およびそれらの医薬組成物 |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6518270B1 (enExample) |
| EP (1) | EP1042324B1 (enExample) |
| JP (1) | JP2001525322A (enExample) |
| KR (1) | KR20010032559A (enExample) |
| CN (1) | CN1142933C (enExample) |
| AR (1) | AR016972A1 (enExample) |
| AT (1) | ATE233263T1 (enExample) |
| AU (1) | AU752187C (enExample) |
| BR (1) | BR9814755A (enExample) |
| CA (1) | CA2311798A1 (enExample) |
| CZ (1) | CZ292349B6 (enExample) |
| DE (1) | DE69811735T2 (enExample) |
| DK (1) | DK1042324T3 (enExample) |
| EE (1) | EE04060B1 (enExample) |
| ES (1) | ES2191356T3 (enExample) |
| HU (1) | HUP0100601A3 (enExample) |
| ID (1) | ID24730A (enExample) |
| IL (1) | IL136145A0 (enExample) |
| IS (1) | IS5486A (enExample) |
| MY (1) | MY121032A (enExample) |
| NO (1) | NO315704B1 (enExample) |
| NZ (1) | NZ504355A (enExample) |
| PL (1) | PL340920A1 (enExample) |
| PT (1) | PT1042324E (enExample) |
| RU (1) | RU2241000C2 (enExample) |
| SE (1) | SE9704404D0 (enExample) |
| SK (1) | SK283904B6 (enExample) |
| TR (1) | TR200001530T2 (enExample) |
| TW (1) | TW515798B (enExample) |
| UA (1) | UA70932C2 (enExample) |
| WO (1) | WO1999028322A1 (enExample) |
| ZA (1) | ZA9810468B (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997025429A1 (en) | 1996-01-04 | 1997-07-17 | Rican Limited | Helicobacter pylori bacterioferritin |
| SE9704404D0 (sv) | 1997-11-28 | 1997-11-28 | Astra Ab | New compounds |
| DE60017180T2 (de) | 1999-10-08 | 2005-12-08 | Affinium Pharmaceuticals, Inc., Toronto | Fab i inhibitoren |
| CA2444597A1 (en) * | 2001-04-06 | 2002-10-06 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
| JP2003119140A (ja) * | 2001-08-08 | 2003-04-23 | Sankyo Co Ltd | ピロロピリダジン化合物を含有する医薬 |
| JP2005530739A (ja) | 2002-04-19 | 2005-10-13 | セルラー ジェノミクス，インコーポレーテッド | イミダゾ［１，２−ａ］ピラジン−８−イルアミン、生成方法、および使用方法 |
| WO2004022562A1 (en) | 2002-09-09 | 2004-03-18 | Cellular Genomics, Inc. | 6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF |
| WO2004029058A1 (ja) * | 2002-09-25 | 2004-04-08 | Sankyo Company, Limited | 血中ガストリン濃度上昇の抑制のための医薬組成物 |
| WO2004029057A1 (ja) * | 2002-09-25 | 2004-04-08 | Sankyo Company, Limited | 内臓痛の治療または予防のための医薬組成物 |
| AU2003298937A1 (en) * | 2002-12-06 | 2004-06-30 | Affinium Pharmaceuticals, Inc. | Heterocyclic compounds, methods of making them and their use in therapy |
| WO2004072081A1 (en) | 2003-02-10 | 2004-08-26 | Cellular Genomics, Inc. | Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity |
| AR043002A1 (es) * | 2003-02-18 | 2005-07-13 | Altana Pharma Ag | Imidazopirazinas 6-substituidos |
| CA2519429C (en) * | 2003-03-17 | 2013-08-06 | Affinium Pharmaceuticals, Inc. | Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics |
| US7405295B2 (en) | 2003-06-04 | 2008-07-29 | Cgi Pharmaceuticals, Inc. | Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds |
| WO2005005429A1 (en) | 2003-06-30 | 2005-01-20 | Cellular Genomics, Inc. | Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds |
| US7259164B2 (en) | 2003-08-11 | 2007-08-21 | Cgi Pharmaceuticals, Inc. | Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity |
| CA2544325A1 (en) | 2003-11-03 | 2005-05-12 | Astrazeneca Ab | Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux |
| US8450307B2 (en) * | 2004-06-04 | 2013-05-28 | Affinium Pharmaceuticals, Inc. | Therapeutic agents, and methods of making and using the same |
| WO2006011670A1 (ja) * | 2004-07-28 | 2006-02-02 | Takeda Pharmaceutical Company Limited | ピロロ［２，３－ｃ］ピリジン化合物、その製造方法および用途 |
| AU2005268767A1 (en) * | 2004-08-02 | 2006-02-09 | Altana Pharma Ag | 5-substituted 1H-pyrrolo[3,2-B]pyridines |
| CA2579127C (en) | 2004-09-03 | 2011-08-02 | Yuhan Corporation | Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof |
| JP5126830B2 (ja) | 2004-09-03 | 2013-01-23 | ユーハン・コーポレイション | ピロロ［３，２−ｃ］ピリジン誘導体及びその製造方法 |
| RU2375359C2 (ru) * | 2004-09-03 | 2009-12-10 | Юхан Корпорейшн | ПРОИЗВОДНЫЕ ПИРРОЛО[3, 2-c]ПИРИДИНА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ |
| US7662832B2 (en) | 2004-09-03 | 2010-02-16 | Yuhan Corporation | Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
| US7777040B2 (en) | 2005-05-03 | 2010-08-17 | Cgi Pharmaceuticals, Inc. | Certain substituted ureas, as modulators of kinase activity |
| TW200800213A (en) | 2005-09-02 | 2008-01-01 | Abbott Lab | Novel imidazo based heterocycles |
| EP1973902A2 (en) * | 2005-12-05 | 2008-10-01 | Affinium Pharmaceuticals, Inc. | 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| US7557104B2 (en) | 2006-06-06 | 2009-07-07 | Schering Corporation | Imidazopyrazines as protein kinase inhibitors |
| WO2008009122A1 (en) | 2006-07-20 | 2008-01-24 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as fab i inhibitors |
| EP2125802A4 (en) | 2007-02-16 | 2014-08-20 | Debiopharm Int Sa | SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS |
| JP5496915B2 (ja) | 2008-02-13 | 2014-05-21 | シージーアイ ファーマシューティカルズ，インコーポレーテッド | ６−アリール−イミダゾ［１，２−ａ］ピラジン誘導体、その製造方法、及びその使用方法 |
| EP3123864A1 (en) | 2008-12-08 | 2017-02-01 | Gilead Connecticut, Inc. | Imidazopyrazine syk inhibitors |
| US8450321B2 (en) | 2008-12-08 | 2013-05-28 | Gilead Connecticut, Inc. | 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor |
| EP3552607A3 (en) | 2008-12-08 | 2020-01-15 | Gilead Connecticut, Inc. | Imidazopyrazine syk inhibitors |
| US9562056B2 (en) | 2010-03-11 | 2017-02-07 | Gilead Connecticut, Inc. | Imidazopyridines Syk inhibitors |
| DK2861608T3 (da) | 2012-06-19 | 2019-06-24 | Debiopharm Int Sa | Prodrug-derivater af (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamid |
| KR101810798B1 (ko) | 2013-07-30 | 2017-12-19 | 질레드 코네티컷 인코포레이티드 | Ｓｙｋ 억제제의 다형체 |
| PT3027171T (pt) | 2013-07-30 | 2020-06-18 | Gilead Connecticut Inc | Formulação de inibidores da syk |
| KR20180002888A (ko) | 2013-12-04 | 2018-01-08 | 길리애드 사이언시즈, 인코포레이티드 | 암을 치료하는 방법 |
| GB201321738D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
| TWI735853B (zh) | 2013-12-23 | 2021-08-11 | 美商克洛諾斯生技有限公司 | 脾酪胺酸激酶抑制劑 |
| US9290505B2 (en) | 2013-12-23 | 2016-03-22 | Gilead Sciences, Inc. | Substituted imidazo[1,2-a]pyrazines as Syk inhibitors |
| KR20170029580A (ko) | 2014-07-14 | 2017-03-15 | 길리애드 사이언시즈, 인코포레이티드 | 암을 치료하기 위한 조합물 |
| BR112018016721A2 (pt) | 2016-02-26 | 2018-12-26 | Debiopharm Int Sa | uso de di-hidrogeno fosfato de {6-[(e)-3-{metil[(3-metil-1-benfofuran-2-iol)metil]amino)-3-xopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)-il}metila e composição farmacêutica para tratamento de infecções bacterianas associadas ao pé diabético |
| KR20220070056A (ko) | 2017-08-25 | 2022-05-27 | 길리애드 사이언시즈, 인코포레이티드 | Syk 억제제의 다형체 |
| LT3923914T (lt) | 2019-02-14 | 2023-07-25 | Debiopharm International S.A. | Afabicino kompozicija, jos gamybos būdas |
| JP2022521413A (ja) | 2019-02-22 | 2022-04-07 | クロノス バイオ インコーポレイテッド | Ｓｙｋ阻害剤としての縮合ピラジンの固体形態 |
| CA3139942A1 (en) | 2019-06-14 | 2020-12-17 | Justyna NOWAKOWSKA | Medicament and use thereof for treating bacterial infections involving biofilm |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4507294A (en) | 1982-03-08 | 1985-03-26 | Schering Corp. | Imidazo[1,2-a]pyrazines |
| DE3269604D1 (en) * | 1981-06-26 | 1986-04-10 | Schering Corp | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
| US4725601A (en) * | 1985-06-04 | 1988-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers |
| IL97931A0 (en) | 1990-04-27 | 1992-06-21 | Byk Gulden Lomberg Chem Fab | Pyridazine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
| US5041442A (en) | 1990-07-31 | 1991-08-20 | Syntex (U.S.A.) Inc. | Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion |
| AU8712191A (en) * | 1990-10-15 | 1992-05-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New diazines |
| DK0609328T3 (da) | 1991-10-25 | 1999-10-25 | Byk Gulden Lomberg Chem Fab | Pyrrolo-pyridaziner med gastro-intestinal beskyttelsesvirkning |
| ATE229020T1 (de) | 1994-01-19 | 2002-12-15 | Sankyo Co | Pyrrolopyridazin-derivate |
| SE9602286D0 (sv) | 1996-06-10 | 1996-06-10 | Astra Ab | New compounds |
| SE9700661D0 (sv) | 1997-02-25 | 1997-02-25 | Astra Ab | New compounds |
| SE9704404D0 (sv) | 1997-11-28 | 1997-11-28 | Astra Ab | New compounds |
-
1997
- 1997-11-28 SE SE9704404A patent/SE9704404D0/xx unknown
-
1998
- 1998-11-16 TW TW087118942A patent/TW515798B/zh active
- 1998-11-16 AR ARP980105799A patent/AR016972A1/es unknown
- 1998-11-16 ZA ZA9810468A patent/ZA9810468B/xx unknown
- 1998-11-17 MY MYPI98005216A patent/MY121032A/en unknown
- 1998-11-18 UA UA2000052801A patent/UA70932C2/uk unknown
- 1998-11-18 JP JP2000523214A patent/JP2001525322A/ja active Pending
- 1998-11-18 SK SK674-2000A patent/SK283904B6/sk unknown
- 1998-11-18 BR BR9814755-2A patent/BR9814755A/pt not_active Application Discontinuation
- 1998-11-18 KR KR1020007005804A patent/KR20010032559A/ko not_active Ceased
- 1998-11-18 NZ NZ504355A patent/NZ504355A/en unknown
- 1998-11-18 ID IDW20000987A patent/ID24730A/id unknown
- 1998-11-18 AU AU13565/99A patent/AU752187C/en not_active Ceased
- 1998-11-18 IL IL13614598A patent/IL136145A0/xx unknown
- 1998-11-18 EE EEP200000315A patent/EE04060B1/xx not_active IP Right Cessation
- 1998-11-18 US US09/194,823 patent/US6518270B1/en not_active Expired - Lifetime
- 1998-11-18 DK DK98957270T patent/DK1042324T3/da active
- 1998-11-18 DE DE69811735T patent/DE69811735T2/de not_active Expired - Fee Related
- 1998-11-18 PL PL98340920A patent/PL340920A1/xx not_active Application Discontinuation
- 1998-11-18 CZ CZ20001947A patent/CZ292349B6/cs not_active IP Right Cessation
- 1998-11-18 WO PCT/SE1998/002091 patent/WO1999028322A1/en not_active Ceased
- 1998-11-18 AT AT98957270T patent/ATE233263T1/de not_active IP Right Cessation
- 1998-11-18 ES ES98957270T patent/ES2191356T3/es not_active Expired - Lifetime
- 1998-11-18 CN CNB98813344XA patent/CN1142933C/zh not_active Expired - Fee Related
- 1998-11-18 EP EP98957270A patent/EP1042324B1/en not_active Expired - Lifetime
- 1998-11-18 HU HU0100601A patent/HUP0100601A3/hu unknown
- 1998-11-18 TR TR2000/01530T patent/TR200001530T2/xx unknown
- 1998-11-18 CA CA002311798A patent/CA2311798A1/en not_active Abandoned
- 1998-11-18 RU RU2000113729/04A patent/RU2241000C2/ru not_active IP Right Cessation
- 1998-11-18 PT PT98957270T patent/PT1042324E/pt unknown
-
2000
- 2000-05-10 IS IS5486A patent/IS5486A/is unknown
- 2000-05-26 NO NO20002721A patent/NO315704B1/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001525322A5 (enExample) | ||
| JP2004504323A5 (enExample) | ||
| JP2004518675A5 (enExample) | ||
| EP0283970A3 (en) | New peptide compounds, a process for the preparation thereof and pharmaceutical composition comprising the same | |
| JPH10130104A5 (enExample) | ||
| JP2001518459A5 (enExample) | ||
| JP2001519410A5 (enExample) | ||
| JP2004500347A5 (enExample) | ||
| EP1652847A3 (en) | Quinoline and quinazoline derivatives for the treatment of tumors | |
| WO2000061783A3 (en) | Process for preparing inhibitors of nucleoside metabolism | |
| JP2001525411A5 (enExample) | ||
| EP1038875A3 (en) | Imidazopyridine derivatives and process for making them | |
| EP1462447A3 (en) | Method for the preparation of pure citalopram | |
| RU2006106727A (ru) | Селективный синтез cf3-замещенных пиримидинов | |
| CA2415683A1 (en) | Indoloquinazolinones | |
| JP2004525178A5 (enExample) | ||
| JP2003511372A5 (enExample) | ||
| WO2004029064A8 (en) | (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof | |
| JP2003509494A5 (enExample) | ||
| JP2004522795A5 (enExample) | ||
| JP2005526073A5 (enExample) | ||
| RU2001116601A (ru) | Новые производные пиримидина и способы их получения | |
| IL147668A0 (en) | A process for the preparation of venlafaxin | |
| EP0970964A3 (en) | Method for producing titanium complex | |
| JPH09176630A5 (enExample) |